COGT
Cogent Biosciences Inc
NASDAQ: COGT · HEALTHCARE · BIOTECHNOLOGY
$35.87
-1.29% today
Updated 2026-04-29
Market cap
$6.29B
P/E ratio
—
P/S ratio
861.15x
EPS (TTM)
$-2.16
Dividend yield
—
52W range
$5 – $44
Volume
2.1M
Cogent Biosciences Inc (COGT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-73.70%
ROA
-32.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $2.99M | $-6.59M | 100.00% | -220.76% | -220.76% |
| 2016 | $6.36M | $-18.12M | 100.00% | -300.08% | -285.19% |
| 2017 | $8.36M | $-25.49M | 100.00% | -312.82% | -304.93% |
| 2018 | $9.73M | $-34.53M | 100.00% | -369.89% | -354.76% |
| 2019 | $22.50M | $-30.27M | 100.00% | -143.02% | -134.55% |
| 2020 | $7.87M | $-74.81M | -227.00% | -1,044.33% | -950.43% |
| 2021 | $0.00 | $-72.27M | — | — | — |
| 2022 | $0.00 | $-132.64M | — | — | — |
| 2023 | $0.00 | $-192.41M | — | — | — |
| 2024 | $0.00 | $-255.86M | — | — | — |
| 2025 | $0.00 | $-328.94M | — | — | — |